CD19 and neoplasm: Flow cytometry to determine the immunophenotype of the tumor cells typically demonstrates the expression of B-cell associated antigens (CD19, CD20, and CD22), CD45, and CD30 (weak) and an absence of surface immunoglobulins, CD5, and CD10 [2].